10-Q: MariMed Inc. Reports Q2 2024 Results, Revenue Up 10.7% Year-Over-Year

MariMed Inc. saw a 10.7% increase in revenue year-over-year in the second quarter of 2024, driven by wholesale growth, while also reporting a net loss.

Summary

• MariMed Inc. reported a revenue of $40.4 million for the three months ended June 30, 2024, a 10.7% increase compared to $36.5 million in the same period last year.
• The company's gross profit was $16.9 million, with a gross margin of 41.8%.
• Operating expenses totaled $15.9 million, including personnel, marketing, and general and administrative costs.
• The company reported a net loss of $1.65 million, or $0.00 per share, for the quarter.
• For the six months ended June 30, 2024, revenue was $78.4 million, a 10.5% increase from $70.9 million in the same period last year.
• The net loss for the first six months of 2024 was $2.9 million, or $0.01 per share.
• The company completed two acquisitions during the quarter, Allgreens Dispensary, LLC and Our Community Wellness & Compassionate Care Center, Inc.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While revenue growth is positive, the net loss and increased operating expenses temper the overall sentiment. The company is making strategic moves with acquisitions and debt refinancing, but profitability remains a concern.

Positives

• The company experienced a significant increase in wholesale revenue, indicating strong growth in that segment.
• Retail operations in Maryland, Massachusetts and Ohio all reported higher retail revenue in the three months ended June 30, 2024 compared to the same prior year period.
• The company successfully completed two acquisitions, expanding its footprint in Illinois and Maryland.
• The company's new credit facility has allowed it to unencumber its operating assets in Illinois, Ohio, and Delaware, as well as its branded products, providing additional levers for future loans at attractive rates if it chooses to increase its borrowings.

Negatives

• The company reported a net loss of $1.65 million for the quarter and $2.9 million for the first six months of 2024.
• The company's gross margin decreased from 44.8% to 41.8% in Q2 2024.
• Operating expenses increased by 24.4% in Q2 2024 compared to Q2 2023.
• The company's retail operations in Illinois reported lower revenue in the aggregate.
• Real estate rentals and licensing fees decreased in the three months ended June 30, 2024 compared to the three months ended June 30, 2023.

Risks

• The company's profitability is impacted by Section 280E of the Internal Revenue Code, which prohibits the deduction of certain ordinary business expenses.
• The company's future performance is subject to changes in demand for its services and products, changes in the law and its enforcement, timing and outcome of regulatory processes, and changes in the economic environment.
• The company's ability to raise additional cash through financing activities is a risk to its future operations.
• The company is subject to legal claims from time to time.

Future Outlook

The company is focused on executing its strategic growth plan, including completing acquisitions, increasing revenue organically, expanding its footprint, and increasing product brand revenue. The company believes its current cash and future funding opportunities will be sufficient to meet its anticipated cash needs for at least the next twelve months.

Management Comments

• Management believes that Adjusted EBITDA is a useful measure to assess our performance and liquidity, as it provides meaningful operating results by excluding the effects of expenses that are not reflective of our operating business performance.
• Management uses Adjusted EBITDA to understand and compare operating results across accounting periods, and for financial and operational decision-making.

Industry Context

The company operates in the rapidly evolving cannabis industry, which is subject to changing regulations and market conditions. The company's performance is influenced by the legalization of cannabis in various states and the increasing acceptance of cannabis products.

Comparison to Industry Standards

• The company's revenue growth of 10.7% in Q2 2024 is comparable to other multi-state operators in the cannabis industry, although some competitors may have experienced higher growth rates.
• The company's gross margin of 41.8% is within the range of industry averages, but some competitors may have higher margins due to economies of scale or more efficient operations.
• The company's net loss is not uncommon in the cannabis industry, as many companies are still investing heavily in growth and expansion.
• The company's focus on acquisitions and expansion is a common strategy among multi-state operators in the cannabis industry, as they seek to increase their market share and geographic reach.
• The company's debt refinancing is a positive step, as it reduces its interest expense and provides more financial flexibility. Other cannabis companies have also been refinancing their debt to take advantage of lower interest rates.

Corporate Governance

Legal Proceedings

• There has been no material change to the status of the company's previously reported legal proceedings.

Related Party Transactions

• The company leases its corporate offices from an entity in which the CEO has an investment interest.
• The company procures nutrients, lab equipment, cultivation supplies, furniture, and tools from an entity owned by the family of the COO.
• The company pays royalties on the revenue generated from its Betty's Eddies product line to an entity owned by the COO and CRO.
• One of the company's majority-owned subsidiaries paid distributions to the CEO, who owns a minority equity interest in such subsidiary.
• The CEO and COO purchased membership units of Mari Holdings Metropolis, LLC from the previous minority interest-holder.
• The company's mortgages with Bank of New England and DuQuoin State Bank were personally guaranteed by the CEO.

Stakeholder Impact

• Shareholders may be concerned about the net loss, but encouraged by the revenue growth and strategic acquisitions.
• Employees may be impacted by the company's expansion and hiring activities.
• Customers may benefit from the company's expanded product offerings and retail locations.
• Suppliers may see increased business opportunities as the company grows.
• Creditors may be reassured by the company's debt refinancing and improved financial flexibility.

Next Steps

• The company will continue to focus on executing its strategic growth plan.
• The company will work to complete the acquisition of First State Compassion Center.
• The company will continue to increase revenue organically in states where it currently does business.
• The company will expand its footprint into high-growth legal cannabis states.
• The company will increase product brand revenue by introducing new, innovative products.

Key Dates

Keywords

cannabis, revenue, acquisition, wholesale, retail, dispensary, net loss, operating expenses, gross profit, licenses